+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cancer Registry Software Market, by Type, by Deployment Type, by Component, by End User, by Country, Industry Analysis and Forecast, 2019 - 2025

  • PDF Icon

    Report

  • 85 Pages
  • February 2020
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5006202
The Latin America, Middle East and Africa Cancer Registry Software Market is expected to witness market growth of 11.36% CAGR during the forecast period (2019-2025).

The cancer registry program helps to simplify data collection for national and state registries, further helping to monitor the effectiveness of different treatment strategies. In addition, the data collected by the state registries help to better identify and treat the disease. The data collected are important to attack risk factors, like sun exposure, tobacco use, or certain environmental factors, including chemical and radiation exposure. Such information is also needed for places to be identified where screening and treatment services should be tracked and enhanced. In addition, registry data are useful for research institutes to estimate the efficacy of the cancer control, treatment, and prevention program.

The cancer registry system in Fars province (South Iran) was considered to be effective in terms of complete coverage and age detail. However, there was a deficiency in recording patients' phone number and address, and father's name. Following the significant inefficiencies, enhancing hardware and software resources, education and encouragement in all public and private sectors involved in the cancer registry system and paying more attention to epidemiological research have been carried out to improve the efficiency of the cancer registry program.

Based on Type, the market is segmented into Integrated and Standalone. Based on Deployment Type, the market is segmented into On-premise and Cloud-based. Based on Component, the market is segmented into Commercial and Public. Based on End User, the market is segmented into Government & Third party, Research Centers, Hospital & Medical Centers, Private Payers and Pharma Biotech & Medical Device Suppliers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, McKesson Corporation, Conduent, Incorporated, Elekta AB, Ordinal Data, Inc., Onco, Inc., C/Net Solutions, Rocky Mountain Cancer Data System, Electronic Registry System, Inc., and Himagine Solutions, Inc.

Scope of the Study

Market Segmentation:

By Type
  • Integrated
  • Standalone

By Deployment Type
  • On-premise
  • Cloud-based

By Component
  • Commercial
  • Public

By End User
  • Government & Third party
  • Research Centers
  • Hospital & Medical Centers
  • Private Payers
  • Pharma Biotech & Medical Device Suppliers

By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled
  • IBM Corporation
  • McKesson Corporation
  • Conduent, Incorporated
  • Elekta AB
  • Ordinal Data, Inc.
  • Onco, Inc.
  • C/Net Solutions
  • Rocky Mountain Cancer Data System
  • Electronic Registry System, Inc.
  • Himagine Solutions, Inc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Latin America, Middle East and Africa (LAMEA) Cancer Registry Software Market, by Type
1.4.2 Latin America, Middle East and Africa (LAMEA) Cancer Registry Software Market, by Deployment Type
1.4.3 Latin America, Middle East and Africa (LAMEA) Cancer Registry Software Market, by Component
1.4.4 Latin America, Middle East and Africa (LAMEA) Cancer Registry Software Market, by End User
1.4.5 Latin America, Middle East and Africa (LAMEA) Cancer Registry Software Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Cancer Registry Software Market by Type
3.1 LAMEA Integrated Cancer Registry Software Market by Country
3.2 LAMEA Standalone Cancer Registry Software Market by Country
Chapter 4. LAMEA Cancer Registry Software Market by Deployment Model
4.1 LAMEA On-premise Cancer Registry Software Market by Country
4.2 LAMEA Cloud-based Cancer Registry Software Market by Country
Chapter 5. LAMEA Cancer Registry Software Market by Component
5.1 LAMEA Commercial Cancer Registry Software Market by Country
5.2 LAMEA Public Cancer Registry Software Market by Country
Chapter 6. LAMEA Cancer Registry Software Market by End User
6.1 LAMEA Government & Third party Market by Country
6.2 LAMEA Research Centers Market by Country
6.3 LAMEA Hospital & Medical Centers Market by Country
6.4 LAMEA Private Payers Market by Country
6.5 LAMEA Pharma biotech & medical device suppliers Market by Country
Chapter 7. LAMEA Cancer Registry Software Market by Country
7.1 Brazil Cancer Registry Software Market
7.1.1 Brazil Cancer Registry Software Market by Type
7.1.2 Brazil Cancer Registry Software Market by Deployment Model
7.1.3 Brazil Cancer Registry Software Market by Component
7.1.4 Brazil Cancer Registry Software Market by End User
7.2 Argentina Cancer Registry Software Market
7.2.1 Argentina Cancer Registry Software Market by Type
7.2.2 Argentina Cancer Registry Software Market by Deployment Model
7.2.3 Argentina Cancer Registry Software Market by Component
7.2.4 Argentina Cancer Registry Software Market by End User
7.3 UAE Cancer Registry Software Market
7.3.1 UAE Cancer Registry Software Market by Type
7.3.2 UAE Cancer Registry Software Market by Deployment Model
7.3.3 UAE Cancer Registry Software Market by Component
7.3.4 UAE Cancer Registry Software Market by End User
7.4 Saudi Arabia Cancer Registry Software Market
7.4.1 Saudi Arabia Cancer Registry Software Market by Type
7.4.2 Saudi Arabia Cancer Registry Software Market by Deployment Model
7.4.3 Saudi Arabia Cancer Registry Software Market by Component
7.4.4 Saudi Arabia Cancer Registry Software Market by End User
7.5 South Africa Cancer Registry Software Market
7.5.1 South Africa Cancer Registry Software Market by Type
7.5.2 South Africa Cancer Registry Software Market by Deployment Model
7.5.3 South Africa Cancer Registry Software Market by Component
7.5.4 South Africa Cancer Registry Software Market by End User
7.6 Nigeria Cancer Registry Software Market
7.6.1 Nigeria Cancer Registry Software Market by Type
7.6.2 Nigeria Cancer Registry Software Market by Deployment Model
7.6.3 Nigeria Cancer Registry Software Market by Component
7.6.4 Nigeria Cancer Registry Software Market by End User
7.7 Rest of LAMEA Cancer Registry Software Market
7.7.1 Rest of LAMEA Cancer Registry Software Market by Type
7.7.2 Rest of LAMEA Cancer Registry Software Market by Deployment Model
7.7.3 Rest of LAMEA Cancer Registry Software Market by Component
7.7.4 Rest of LAMEA Cancer Registry Software Market by End User
Chapter 8. Company Profiles
8.1 IBM Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 McKesson Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.3 Conduent, Incorporated
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Research & Development Expense
8.3.4 Recent strategies and developments:
8.3.4.1 Product Launches and Product Expansions:
8.4 Elekta AB
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 Ordinal Data, Inc.
8.5.1 Company Overview
8.6 Onco, Inc.
8.6.1 Company Overview
8.7 C/Net Solutions
8.7.1 Company Overview
8.8 Rocky Mountain Cancer Data System
8.8.1 Company Overview
8.9 Electronic Registry System, Inc.
8.9.1 Company Overview
8.1 Himagine Solutions, Inc.
8.10.1 Company Overview

Companies Mentioned

  • IBM Corporation
  • McKesson Corporation
  • Conduent, Incorporated
  • Elekta AB
  • Ordinal Data, Inc.
  • Onco, Inc.
  • C/Net Solutions
  • Rocky Mountain Cancer Data System
  • Electronic Registry System, Inc.
  • Himagine Solutions, Inc.

Methodology

Loading
LOADING...